Dr. Lal PathLabs Schedules Board Meeting on April 30, 2026 for Q4FY26 and FY26 Financial Results Approval
Dr. Lal PathLabs has scheduled a board meeting for April 30, 2026, to consider and approve audited standalone and consolidated financial results for Q4FY26 and FY26. The company has also announced trading window closure from April 1-May 2, 2026, in compliance with SEBI insider trading regulations.